- Social Responsibility
- Social Responsibility
- Our Giving
- Corporate Social Responsibility
- Be The First Tobacco-Free Generation
- Our Impact
- Community Contacts
- Thought Leadership
- Search Jobs
- Investor Story
- Results Center
- 2017 In Review
- Financial Information
- SEC Filings
- Events & Presentations
- Stock Information
- Corporate Governance
- Investor Resources
Year in Review: The Top 5 Stories of 2017
Looking back over the past year at the most read stories on CVSHealth.com, key themes that captured our readers’ attention included the opioid epidemic and prescription drug affordability. Both topics are not only trending on this website but are also pervasive on mainstream news outlets. In addition, these are areas where CVS Health has launched new efforts over the past year, and both will continue to be a focus for the company moving forward.
In order of popularity, here are the most read articles over the past year.
- CVS Health Responds to Nation’s Opioid Crisis: Opioid misuse and abuse have reached epidemic proportions. In September, CVS Health took bold steps to enhance its efforts to address the nation’s crisis, including efforts to educate patients; ensure appropriate opioid use; increase access to appropriate medication disposal and fund community-based treatment and support.
- Protecting Consumers in an Environment of Rising Drug Prices: The high cost of prescriptions is becoming more commonplace and can jeopardize access to medications and put financial strain on patients and taxpayers. This article discusses how pharmacy benefit managers (PBMs) can help keep drug prices in check and keep out-of-pocket costs low for consumers through a variety of strategies and innovative programs.
- Time to Put Limits on Opioid Prescribing: This is a reprint of an op-ed for Morning Consult, authored by Larry Merlo, President and CEO of CVS Health, in July. In it, Mr. Merlo, called for limits on opioid prescribing and highlighted findings from a CVS Health survey, which found that nearly 1 in 3 people in the U.S. has been personally affected by this epidemic.
- Lowest Cash Price Epinephrine Auto-Injector Now Available at CVS Pharmacy: CVS Pharmacy announced that patients can now purchase the authorized generic for Adrenaclick®, a Food and Drug Administration (FDA)-approved device with the same active ingredient as other epinephrine auto-injector devices, at the lowest cash price in the market.
- Promoting Competition to Reduce Drug Spending: A panel of experts at The Brookings Institute, including CVS Health Chief Policy and External Affairs Officer and General Counsel Tom Moriarty, weighed in on the pharmaceutical supply chain and the critical role that generic medications and biosimilars play in keeping rising drug prices in check and driving value for the system.
NALOXONE AVAILABILITY ACROSS THE UNITED STATES
CVS Pharmacy patients in 48 states and the District of Columbia now have access to the opioid overdose-reversal drug, naloxone.
Follow our commitment to drug abuse prevention as we increase access to the life-saving opioid overdose reversal drug.